EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool

Rogério Caixinha Algarvio, Jaime Conceição, Pedro Pereira Rodrigues, Inês Ribeiro, Renato Ferreira-da-Silva

International Journal of Clinical Pharmacy · 2025-08 · 47 (4) · 932-944

DOI: 10.1007/s11096-025-01975-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Clinical Pharmacy, online erschienen am 30.07.2025. Verfasst von Rogério Caixinha Algarvio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences and Technology, University of Algarve, Faro, Portugal. Hauptthemen laut MEDLINE: Pharmacovigilance, Artificial Intelligence, Drug-Related Side Effects and Adverse Reactions, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade do Porto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pharmacovigilance is vital for monitoring adverse drug reactions (ADRs) and ensuring drug safety. Traditional methods are slow and inconsistent, but artificial intelligence (AI), through automation and advanced analytics, improves efficiency and accuracy in managing increasing data complexity.

Aim

To explore AI’s practical applications in pharmacovigilance, focusing on efficiency, process acceleration, and task automation. It also examines the use of an expert-defined Bayesian network for causality assessment in a Pharmacovigilance Centre, demonstrating its impact on decision-making.

Method

A comprehensive literature narrative review was conducted in MEDLINE (via PubMed), Scopus, and Web of Science using a set of targeted keywords, including but not limited to “pharmacovigilance”, “artificial intelligence”, “adverse drug reactions” and “drug safety”. Relevant studies were analysed without restrictions on publication year or language. The search was carried out in January 2025.

Results

AI has greatly improved pharmacovigilance by streamlining signal detection, surveillance, and ADR reporting automation. Techniques like data mining and automated signal detection have expedited safety signal identification, while duplicate detection has enhanced data precision in safety evaluations. AI has also refined real-world evidence analysis, deepening drug safety and efficacy insights. Predictive models now anticipate ADRs and drug-drug interactions, enabling proactive patient care. At a regional pharmacovigilance center, the implementation of an expert-defined Bayesian network has optimized causality assessment, reducing processing times from days to hours, minimizing subjectivity, and improving the reliability of drug safety evaluations.

Conclusion

AI holds significant promise for enhancing pharmacovigilance practices, yet its practical application remains primarily confined to academic research, with integration hindered by data quality issues, regulatory barriers, and the need for more transparent algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceArtificial IntelligenceDrug-Related Side Effects and Adverse ReactionsAdverse Drug Reaction Reporting SystemsBayes TheoremHumansData Mining

Stichwörter der Autor:innen

Artificial intelligenceDrug-related side effects and adverse reactionsMachine learning data miningNatural language processingPharmacovigilance

Autor:innen und Institutionen

  • Faculty of Sciences and Technology, University of Algarve, Faro, Portugal.
  • Algarve Biomedical Centre Research Institute (ABC-Ri), University of Algarve, Faro, Portugal.
  • Centre for Interdisciplinary Studies (CEIS20), University of Coimbra, Coimbra, Portugal.
  • RISE-Health, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Porto Pharmacovigilance Centre, Faculty of Medicine of the University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
  • Algarve Biomedical Centre Research Institute (ABC-Ri), University of Algarve, Faro, Portugal. renato.ivos@gmail.com.

Förderung

  • Universidade do Porto

Zitieren

APA

Algarvio, R. C., Conceição, J., Rodrigues, P. P., Ribeiro, I., & Ferreira-da-Silva, R. (2025). Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool. International Journal of Clinical Pharmacy, 47(4), 932-944. https://doi.org/10.1007/s11096-025-01975-3

Vancouver

Algarvio RC, Conceição J, Rodrigues PP, Ribeiro I, Ferreira-da-Silva R. Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool. International Journal of Clinical Pharmacy. 2025;47(4):932-944. doi:10.1007/s11096-025-01975-3

BibTeX
@article{Algarvio2025,
  author = {Algarvio, Rogério Caixinha and Conceição, Jaime and Rodrigues, Pedro Pereira and Ribeiro, Inês and Ferreira-da-Silva, Renato},
  title = {Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  volume = {47},
  number = {4},
  pages = {932--944},
  doi = {10.1007/s11096-025-01975-3}
}
Kostenlos starten →